Browse > Article

Role of Intracellular $Ca^{2+}$ in the Lovastatin-Induced Stimulation of Melanin Synthesis in B16 Melanoma Cells  

Lee, Yong Soo (College of Pharmacy, Duksung Women's University)
Publication Information
YAKHAK HOEJI / v.57, no.1, 2013 , pp. 24-31 More about this Journal
Abstract
Although statins, inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase, have been shown to increase melanin synthesis, the exact mechanism of this action is not fully understood. In this study we investigated the possible involvement of intracellular $Ca^{2+}$ signal in the mechanism of stimulation of melanin synthesis induced by lovastatin in B16 cells. Lovastatin stimulated the production of melanin in a dose-dependent manner in the cells. Treatment with mevalonate, FPP and GGPP, precursors of cholesterol, did not significantly suppress the lovastatin-induced melanin production, suggesting that inhibition of cholesterol synthesis may not be involved in the mechanism of the action of lovastatin. In addition, lovastatin did not significantly alter the cAMP concentration and the stimulated production of melanin by lovastatin was not significantly changed by treatment with H89, a potent inhibitor of protein kinase A, which demonstrates that cAMP pathway may not be involved. However, lovastatin increased intracellular $Ca^{2+}$ concentration in a dose-related fashion. Treatment with EGTA, an extracellular $Ca^{2+}$ chelator did not significantly alter the lovastatin-induced intracellular $Ca^{2+}$ increase and melanin synthesis, whereas intracellular $Ca^{2+}$ reduction with BAPTA/AM and intracellular $Ca^{2+}$ release blockers (dantrolene and TMB-8) completely blunted these actions of lovastatin. Taken together, these results suggest that the intracellular $Ca^{2+}$ release may play an important role in the lovastatin-induced stimulation of melanin synthesis in B16 cells. These results further suggest that lovastatin may be useful for the treatment of hypopigmentation disorders, such as vitiligo.
Keywords
lovastatin; melanogenesis; cAMP; $Ca^{2+}$ signal; hypopigmentation; B16 melanoma cell;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Zhou, Q. and Liao, J. K. : Pleiotropic effects of statins. Basic research and clinical perspectives. Circ. J. 74, 818 (2010).   DOI   ScienceOn
2 Hatzigeorgiou, C. and Jackson, J. L. : Hydroxymethylglutarylcoenzyme A reductase inhibitors and osteoporosis: a metaanalysis. Osteoporos. Int. 16, 990 (2005).   DOI
3 Szczepanska-Szerej, A., Kurzepa, J., Wojczal, J. and Stelmasiak, Z. : Simvastatin-induced prevention of the increase in TNFlevel in the acute phase of ischemic stroke. Pharmacol. Rep. 59, 94 (2007).
4 Saito, A., Saito, N., Mol, W., Furukawa, H., Tsutsumida, A., Oyama, A., Sekido, M., Sasaki, S. and Yamamoto, Y. : Simvastatin inhibits growth via apoptosis and the induction of cell cycle arrest in human melanoma cells. Melanoma Res. 18, 85 (2008).   DOI   ScienceOn
5 Glynn, S. A., O'Sullivan, D., Eustace, A. J., Clynes, M. and O'Donovan, N. : The 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors, simvastatin, lovastatin and mevastatin inhibit proliferation and invasion of melanoma cells. BMC Cancer 8, 9 (2008).   DOI   ScienceOn
6 Lee, Y. S. : Lovastatin induces apoptotic cell death by activation of intracellular $Ca^{2+}$ signal in HepG2 human hepatoma cells. J. Appl. Pharmacol. 15, 137 (2007).   DOI   ScienceOn
7 Schallreuter, K. U., Hasse, S., Rokos, H., Chavan, B., Shalbaf, M., Spencer, J. D. and Wood, J. M. : Cholesterol regulates melanogenesis in human epidermal melanocytes and melanoma cells. Exp. Dermatol. 18, 680 (2009).   DOI   ScienceOn
8 Galus, R., Niderla, J., Sladowski, D., Sajjad, E., Wlodarski, K. and Jozwiak, J. : Fluvastatin increases tyrosinase synthesis induced by a-melanocyte-stimulating hormone in B16F10 melanoma cells. Pharmacol. Rep. 62, 164 (2010).   DOI
9 Copaja, M., Venegas, D., Aranguiz, P., Canales, J., Vivar, R., Avalos, Y., Garcia, L., Chiong, M., Olmedo, I., Catalan, M., Leyton, L., Lavandero, S. and Diaz-Araya, G. : Simvastatin disrupts cytoskeleton and decreases cardiac fibroblast adhesion, migration and viability. Toxicology 294, 42 (2012).   DOI   ScienceOn
10 Yoshioka, S., Terashita, T., Yoshizumi, H. and Shirasaka, N. : Inhibitory effects of whisky polyphenols on melanogenesis in mouse B16 melanoma cells. Biosci. Biotechnol. Biochem. 75, 2278 (2011).   DOI   ScienceOn
11 Huang, Y. C., Liu, K. C. and Chiou, Y. L. : Melanogenesis of murine melanoma cells induced by hesperetin, a Citrus hydrolysate-derived flavonoid. Food Chem. Toxicol. 50, 653 (2012).   DOI   ScienceOn
12 Busca, R. and Ballotti, R. : Cyclic AMP a key messenger in the regulation of skin pigmentation. Pigment Cell Res. 13, 60 (2000).   DOI   ScienceOn
13 Bentley, N. J., Eisen, T. and Goding, C.R. : Melanocyte-specific expression of the human tyrosinase promoter: activation by the microphthalmia gene product and role of the initiator. Mol. Cell. Biol. 14, 7996 (1994).   DOI
14 Liang, C. H., Chou, T. H., Tseng, Y. P. and Ding, H. Y. : trans- Caffeic acid stearyl ester from Paeonia suffruticosa inhibits melanin synthesis by cAMP-mediating down-regulation of $\alpha$- melanocyte-stimulating hormone-stimulated melanogenesis signaling pathway in B16 cells. Biol. Pharm. Bull. 35, 2198 (2012).   DOI
15 deOliveira, A. R., Castrucci, A. M., Visconti, M. A. : Cellular signalling in vertebrate pigment cells. Braz. J. Med. Biol. Res. 29, 1743 (1996).
16 Carsberg, C. J., Jones, K. T., Sharpe, G. R. and Friedmann, P. S. : Intracellular calcium modulates the responses of human melanocytes to melanogenic stimuli. J. Dermatol. Sci. 9, 157 (1995).   DOI   ScienceOn
17 Parker, C. and Sherbet, G. V. : The $Ca^{2+}$ channel blocker verapamil enhances melanogenesis without altering metastatic potential in the B16 murine melanoma. Melanoma Res. 3, 347 (1993).   DOI
18 Jin, S. H., Lee, Y. Y. and Kang, H. Y. : Methyl-$\beta$-cyclodextrin, a specific cholesterol-binding agent, inhibits melanogenesis in human melanocytes through activation of ERK. Arch. Dermatol. Res. 300, 451 (2008).   DOI
19 Schallreuter, K. U., Kothari, S., Chavan, B. and Spencer, J. D. : Regulation of melanogenesis-controversies and new concepts. Exp. Dermatol. 17, 395 (2008).   DOI   ScienceOn
20 Chang, T. S. : An updated review of tyrosinase inhibitors. Int. J. Mol. Sci. 10, 2440 (2009).   DOI   ScienceOn
21 Sposito, A. C. and Chapman, M. J. : Statin therapy in acute coronary syndromes: mechanistic insight into clinical benefit. Arterioscler. Thromb. Vasc. Biol. 22, 1524 (2002).   DOI   ScienceOn
22 Muck, A. O., Seeger, H. and Wallwiener, D. : Inhibitory effect of statins on the proliferation of human breast cancer cells. Int. J. Clin. Pharmacol. Ther. 42, 695 (2004).   DOI
23 Boissy, R. E. : Melanosome transfer to and translocation in the keratinocyte. Exp. Dermatol. 12 Suppl 2, 5 (2003).   DOI   ScienceOn
24 Gillbro, J. M. and Olsson, M. J. : The melanogenesis and mechanisms of skin-lightening agents-existing and new approaches. Int. J. Cosmet. Sci. 33, 210 (2011).   DOI   ScienceOn